Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 29:11:96.
doi: 10.3389/fnmol.2018.00096. eCollection 2018.

Pathophysiology of Long Non-coding RNAs in Ischemic Stroke

Affiliations
Review

Pathophysiology of Long Non-coding RNAs in Ischemic Stroke

Weimin Ren et al. Front Mol Neurosci. .

Abstract

Stroke is a neurological disease with high disability and fatality rates, and ischemic stroke accounts for 75% of all stroke cases. The underlying pathophysiologic processes of ischemic stroke include oxidative stress, toxicity of excitatory amino acids, excess calcium ions, increased apoptosis and inflammation. Long non-coding RNAs (lncRNAs) may participate in the regulation of the pathophysiologic processes of ischemic stroke as indicated by altered expression of lncRNAs in blood samples of acute ischemic stroke patients, animal models of focal cerebral ischemia and oxygen-glucose deprivation (OGD) cell models. Because of the potentially important role, lncRNAs might be useful as biomarkers for the diagnosis, treatment and prognosis of ischemic stroke. This article reviews the functions of lncRNAs in different pathophysiology events of ischemic stroke with a focus on specific lncRNAs that may underlie ischemic stroke pathophysiology and that could therefore serve as potential diagnostic biomarkers and therapeutic targets.

Keywords: diagnostic biomarkers; ischemic stroke; long non-coding RNA; oxygen-glucose deprivation; pathophysiology; therapeutic targets.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Multiple functions of long non-coding RNAs (lncRNAs) in pathophysiological changes of ischemic stroke.

References

    1. Bhattarai S., Pontarelli F., Prendergast E., Dharap A. (2017). Discovery of novel stroke-responsive lncRNAs in the mouse cortex using genome-wide RNA-seq. Neurobiol. Dis. 108, 204–212. 10.1016/j.nbd.2017.08.016 - DOI - PubMed
    1. Boon R. A., Jaé N., Holdt L., Dimmeler S. (2016). Long noncoding RNAs: from clinical genetics to therapeutic targets? J. Am. Coll. Cardiol. 67, 1214–1226. 10.1016/j.jacc.2015.12.051 - DOI - PubMed
    1. Chen Z., Jiang B., Ru X., Sun H., Sun D., Liu X., et al. (2017). Mortality of stroke and its subtypes in China: results from a nationwide population-based survey. Neuroepidemiology 48, 95–102. 10.1159/000477494 - DOI - PubMed
    1. Chen Y. J., Nguyen H. M., Maezawa I., Grössinger E. M., Garing A. L., Köhler R., et al. (2016). The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke. J. Cereb. Blood Flow Metab. 36, 2146–2161. 10.1177/0271678x15611434 - DOI - PMC - PubMed
    1. dela Peña I. C., Yoo A., Tajiri N., Acosta S. A., Ji X., Kaneko Y., et al. (2015). Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis. J. Cereb. Blood Flow Metab. 35, 338–346. 10.1038/jcbfm.2014.208 - DOI - PMC - PubMed

LinkOut - more resources